Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Hemorrhagic | 4 | 2018 | 48 | 1.640 |
Why?
|
| Benzylidene Compounds | 3 | 2019 | 29 | 1.190 |
Why?
|
| Piperidones | 3 | 2019 | 32 | 1.180 |
Why?
|
| Hemoglobins | 3 | 2016 | 118 | 1.040 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 197 | 0.980 |
Why?
|
| Oxidative Stress | 4 | 2020 | 668 | 0.970 |
Why?
|
| Cystathionine beta-Synthase | 3 | 2020 | 31 | 0.960 |
Why?
|
| Resuscitation | 2 | 2016 | 59 | 0.950 |
Why?
|
| Ovarian Neoplasms | 5 | 2022 | 589 | 0.860 |
Why?
|
| Mitochondria | 3 | 2020 | 371 | 0.740 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2019 | 80 | 0.730 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 12 | 0.670 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 60 | 0.650 |
Why?
|
| Brain | 2 | 2015 | 745 | 0.640 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 20 | 0.580 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 31 | 0.580 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 325 | 0.550 |
Why?
|
| Hyperthyroidism | 1 | 2016 | 10 | 0.510 |
Why?
|
| Plasma Substitutes | 1 | 2016 | 5 | 0.510 |
Why?
|
| MicroRNAs | 1 | 2020 | 301 | 0.510 |
Why?
|
| Proteostasis Deficiencies | 1 | 2016 | 5 | 0.510 |
Why?
|
| Ileum | 1 | 2016 | 25 | 0.510 |
Why?
|
| Melatonin | 1 | 2016 | 23 | 0.510 |
Why?
|
| Blood Substitutes | 1 | 2015 | 9 | 0.470 |
Why?
|
| Neuroprotective Agents | 1 | 2015 | 52 | 0.470 |
Why?
|
| Shock | 1 | 2015 | 17 | 0.470 |
Why?
|
| Hippocampus | 1 | 2016 | 191 | 0.460 |
Why?
|
| Metal Nanoparticles | 3 | 2022 | 130 | 0.450 |
Why?
|
| Antioxidants | 1 | 2016 | 223 | 0.440 |
Why?
|
| Neurons | 1 | 2016 | 289 | 0.430 |
Why?
|
| Prolactin | 2 | 2011 | 16 | 0.380 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1461 | 0.340 |
Why?
|
| Gold | 3 | 2022 | 130 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 551 | 0.330 |
Why?
|
| Epitopes | 1 | 2011 | 184 | 0.330 |
Why?
|
| Animals | 11 | 2022 | 10443 | 0.310 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 123 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 128 | 0.280 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 178 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 465 | 0.260 |
Why?
|
| Pyruvic Acid | 2 | 2015 | 16 | 0.240 |
Why?
|
| Nerve Growth Factor | 2 | 2015 | 15 | 0.240 |
Why?
|
| NAD | 3 | 2015 | 103 | 0.240 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 120 | 0.230 |
Why?
|
| Rats | 3 | 2018 | 1581 | 0.230 |
Why?
|
| Liposomes | 2 | 2016 | 145 | 0.230 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 1319 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 540 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2020 | 1436 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2020 | 6 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 23 | 0.170 |
Why?
|
| Pinocytosis | 1 | 2020 | 17 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 62 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 63 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 80 | 0.160 |
Why?
|
| Glycolysis | 1 | 2020 | 90 | 0.160 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 60 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2019 | 12 | 0.160 |
Why?
|
| Humans | 11 | 2022 | 28110 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 10 | 0.160 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 157 | 0.150 |
Why?
|
| DNA Damage | 1 | 2019 | 151 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2020 | 252 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 165 | 0.150 |
Why?
|
| Female | 6 | 2022 | 15159 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2019 | 142 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 149 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 403 | 0.140 |
Why?
|
| Intestine, Small | 1 | 2018 | 66 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 74 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2020 | 988 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 281 | 0.140 |
Why?
|
| Histones | 2 | 2019 | 95 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2020 | 806 | 0.130 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2016 | 5 | 0.130 |
Why?
|
| Mesocricetus | 1 | 2016 | 11 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 58 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2016 | 25 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2016 | 32 | 0.130 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 47 | 0.130 |
Why?
|
| Cell Death | 1 | 2016 | 118 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 39 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2016 | 68 | 0.120 |
Why?
|
| Male | 3 | 2016 | 13498 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2016 | 107 | 0.120 |
Why?
|
| Phosphocreatine | 1 | 2015 | 22 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 22 | 0.120 |
Why?
|
| Glucose-6-Phosphate | 1 | 2015 | 4 | 0.120 |
Why?
|
| Citrate (si)-Synthase | 1 | 2015 | 23 | 0.120 |
Why?
|
| Hexokinase | 1 | 2015 | 16 | 0.120 |
Why?
|
| Ascaris suum | 2 | 2005 | 23 | 0.110 |
Why?
|
| Malate Dehydrogenase | 2 | 2005 | 36 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2015 | 204 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2011 | 257 | 0.100 |
Why?
|
| Binding Sites | 2 | 2011 | 353 | 0.100 |
Why?
|
| Chlamydia | 1 | 2012 | 1 | 0.100 |
Why?
|
| RNA, Small Untranslated | 1 | 2012 | 2 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 632 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 111 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2016 | 287 | 0.100 |
Why?
|
| Time Factors | 1 | 2016 | 1594 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2379 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 156 | 0.090 |
Why?
|
| Receptors, Prolactin | 1 | 2011 | 1 | 0.090 |
Why?
|
| Pituitary Hormones | 1 | 2011 | 4 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2011 | 46 | 0.090 |
Why?
|
| Alanine | 1 | 2011 | 40 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 37 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2011 | 93 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 64 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2011 | 452 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 485 | 0.070 |
Why?
|
| Mutation | 1 | 2011 | 847 | 0.070 |
Why?
|
| Cell Line | 2 | 2019 | 697 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2005 | 79 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 90 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2020 | 267 | 0.050 |
Why?
|
| Malates | 1 | 2003 | 16 | 0.050 |
Why?
|
| Fumarates | 1 | 2003 | 16 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 29 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 137 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 82 | 0.050 |
Why?
|
| Insulin | 1 | 2022 | 322 | 0.040 |
Why?
|
| Hydrogen Sulfide | 1 | 2020 | 32 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 52 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 65 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Interleukin-33 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 17 | 0.040 |
Why?
|
| Hypoxia | 1 | 2020 | 89 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 96 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 56 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2019 | 191 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 246 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 315 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 579 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 179 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 199 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 373 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 95 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1054 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 352 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1578 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 2081 | 0.030 |
Why?
|
| Kinetics | 2 | 2005 | 545 | 0.030 |
Why?
|
| Interferometry | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 208 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 193 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 243 | 0.020 |
Why?
|
| Placental Lactogen | 1 | 2011 | 1 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 586 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 19 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2011 | 15 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 4662 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2005 | 24 | 0.010 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2005 | 17 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2005 | 34 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2005 | 52 | 0.010 |
Why?
|
| Arginine | 1 | 2005 | 42 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 92 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 151 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 74 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 267 | 0.010 |
Why?
|
| Allosteric Site | 1 | 2003 | 11 | 0.010 |
Why?
|
| Pyruvates | 1 | 2003 | 11 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 133 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 103 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 65 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 413 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 608 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 692 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 658 | 0.010 |
Why?
|